Obesity and clinical outcomes in COVID-19 patients without comorbidities, a post-hoc analysis from ORCHID trial
ObjectiveLarge body of studies described individuals with obesity experiencing a worse prognosis in COVID-19. However, the effects of obesity on the prognosis of COVID-19 in patients without comorbidities have not been studied. Therefore, the current study aimed to provide evidence of the relationsh...
Main Authors: | Peng Yu, Ziqi Tan, Zhangwang Li, Yi Xu, Jing Zhang, Panpan Xia, Xiaoyi Tang, Jianyong Ma, Minxuan Xu, Xiao Liu, Yunfeng Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.936976/full |
Similar Items
-
Non-steroidal anti-inflammatory drugs and clinical outcomes in patients with COVID-19
by: Jing Zhang, et al.
Published: (2022-10-01) -
O-GlycNacylation Remission Retards the Progression of Non-Alcoholic Fatty Liver Disease
by: Yicheng Zhou, et al.
Published: (2022-11-01) -
Psychiatric comorbidities and all-cause mortality in epilepsy: A nationwide cohort study
by: Kristijonas Puteikis, et al.
Published: (2022-08-01) -
Identification of necroptosis-related features in diabetic nephropathy and analysis of their immune microenvironent and inflammatory response
by: Kaibo Hu, et al.
Published: (2023-11-01) -
Psychological consequences of childhood obesity: psychiatric comorbidity and prevention
by: Rankin J, et al.
Published: (2016-11-01)